Vestibular schwannomas (VSs) are benign tumors of the vestibulocochlear nerve that often cause significant neurological and functional impairment, affecting patients' overall quality of life (QoL). While clinical assessments have traditionally focused on hearing preservation and tumor control, patients often emphasize other critical symptoms such as dizziness, pain, cognitive difficulties and satisfaction with care....
No actionable change — this is a study protocol; clinicians should await results before adopting the German Vestibular Schwannoma Quality of Life Index in practice.
Validated, language-adapted patient-reported outcome tools are essential for equitable, patient-centered care in vestibular schwannoma management across German-speaking populations.
- 01Multicenter study protocol to validate the German version of the VS-QoL Index.
- 02Vestibular schwannoma is a slow-growing, non-cancerous tumor on the hearing/balance nerve.
- 03Focuses on psychometric testing — checking whether the questionnaire measures what it claims to.
- 04Patient-centered outcomes are the primary focus, not treatment efficacy.
- 05Published in Audiology Research (2026).
- PMID
- 42201122
- DOI
- 10.3390/audiolres16030068.
- Journal
- Audiology Research
- Publication type
- research_article
- Evidence level
- na
- Population
- Vestibular schwannoma patients in German-speaking countries
- Intervention
- German Vestibular Schwannoma Quality of Life Index (psychometric validation)
Primary outcomes
Psychometric properties of the German VS-QoL Index (validity, reliability, responsiveness)